Norges Bank Investment Management »

Intellia Therapeutics shares owned by Norges Bank Investment Management

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Norges Bank Investment Management from 13F filings

Historical chart of Norges Bank Investment Management investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Norges Bank Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Norges Bank Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $16M 536k 30.49
2022-12-31 $30M 857k 34.89
2022-09-30 $37M 662k 55.96
2022-06-30 $31M 606k 51.76
2022-03-31 $36M 501k 72.67
2021-12-31 $52M 442k 118.24
2021-09-30 $82M 612k 134.15
2021-06-30 $67M 415k 161.91
2021-03-31 $39M 489k 80.25
2020-06-30 $315k 15k 21.00
2016-12-31 $886k 68k 13.11